Use of olanzapine compared with clozapine for treatment-resistant schizophrenia in a real-world setting: nationwide register-based study
Background Clozapine is generally considered as the treatment of choice for patients with treatment-resistant schizophrenia (TRS). However, its superiority has recently been questioned because olanzapine has been suggested as non-inferior to clozapine in its effectiveness. Aims We aimed to investi...
Main Authors: | Young Tak Jo, Sung Woo Joo, Soojin Ahn, Youngjae Choi, Jungsun Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2021-09-01
|
Series: | BJPsych Open |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S2056472421009649/type/journal_article |
Similar Items
-
Association Between SIRT1, Cytokines, and Metabolic Syndrome in Schizophrenia Patients With Olanzapine or Clozapine Monotherapy
by: Xinyu Fang, et al.
Published: (2020-11-01) -
Olanzapine-induced Pancytopenia: Case Report
by: A Prajnashree, et al.
Published: (2024-11-01) -
Tubulin/microtubules as novel clozapine targets
by: Mizuki Hino, et al.
Published: (2022-03-01) -
Subcutaneous Olanzapine at the End of Life in a Patient with Schizophrenia and Dysphagia
by: Jonathan Hindmarsh, et al.
Published: (2020-06-01) -
Treatment progress of weight gain and abnormal lipid metabolism in patients with schizophrenia caused by clozapine and olanzapine
by: Kang Li, et al.
Published: (2021-04-01)